Which of the following amino acids is required in the formation of the structure of Haemoglobin?
Carbamazepine can exacerbate medical, neurological, and psychiatric symptoms in patients with which of the following conditions?
Which of the following amino acids is required for the synthesis of hemoglobin?
In hemoglobin, the innate affinity of heme for carbon monoxide is diminished by the presence of which amino acid residue?
Hydrops fetalis due to Hb Barts is lethal because:
Which enzyme is responsible for the conversion of heme to bilirubin?
Release of iron from stores is controlled by?
What is the protein that transports iron from the intestines to the body's tissues?
Which of the following proteins binds to free heme?
Which of the following pigments gives stools their characteristic brown color?
Explanation: ### Explanation **Correct Answer: C. Histidine** **Underlying Concept:** Hemoglobin is a tetrameric protein consisting of four globin chains, each containing a heme group. The iron ($Fe^{2+}$) in the center of the heme molecule must be stabilized to bind oxygen reversibly. This stabilization is provided by **Histidine** residues from the globin chain: 1. **Proximal Histidine (F8):** Directly binds to the iron atom at the 5th coordination position. 2. **Distal Histidine (E7):** Does not bind iron directly but stabilizes the oxygen-binding site and prevents the oxidation of $Fe^{2+}$ to $Fe^{3+}$ (methemoglobin). It also reduces the affinity of heme for Carbon Monoxide (CO). **Analysis of Incorrect Options:** * **A. Copper:** While copper is essential for iron metabolism (via Ceruloplasmin/Ferroxidase), it is not an amino acid, nor is it a structural component of the hemoglobin molecule itself. * **B. Tyrosine:** Though present in the globin chain, it does not play a specific, defining role in the heme-binding pocket or the oxygen-carrying mechanism like Histidine does. * **D. Leucine:** Leucine is a common hydrophobic amino acid found in the interior of the globin folds, but it lacks the specific imidazole ring required for iron coordination. **High-Yield Clinical Pearls for NEET-PG:** * **The Bohr Effect:** Histidine residues (specifically C-terminal His-146) are crucial for the Bohr effect, as they pick up protons ($H^+$) in acidic environments, promoting the release of $O_2$ (Right shift of the dissociation curve). * **Methemoglobinemia:** If the proximal or distal Histidine is mutated (e.g., to Tyrosine), it results in **Hemoglobin M**, where iron stays in the $Fe^{3+}$ state, leading to cyanosis. * **2,3-BPG Binding:** 2,3-BPG binds to a pocket between the beta-globin chains lined with positively charged amino acids, including **Histidine** and Lysine.
Explanation: **Explanation:** The correct answer is **Erythropoietic porphyria** (specifically Acute Intermittent Porphyria or Variegate Porphyria, often grouped under the clinical umbrella of porphyrias exacerbated by drugs). **Mechanism of Action:** Carbamazepine is a potent **Cytochrome P450 (CYP450) enzyme inducer**. When CYP450 enzymes are induced, the liver consumes more **heme** to produce these enzymes. This depletion of the regulatory heme pool triggers a feedback mechanism that upregulates **ALAS1 (delta-aminolevulinate synthase 1)**, the rate-limiting enzyme of heme synthesis. In patients with porphyria, this leads to the massive accumulation of toxic porphyrin precursors (like ALA and PBG), precipitating acute attacks characterized by severe abdominal pain, peripheral neuropathy, and psychiatric disturbances. **Analysis of Incorrect Options:** * **B, C, and D (Epilepsy, Bipolar Disorder, Trigeminal Neuralgia):** These are actually the **primary clinical indications** for Carbamazepine. It is a first-line treatment for trigeminal neuralgia and a standard maintenance therapy for epilepsy and bipolar disorder. Rather than exacerbating these conditions, it stabilizes them. **High-Yield Clinical Pearls for NEET-PG:** * **The "P"s of Acute Intermittent Porphyria:** **P**ainful abdomen, **P**olyneuropathy, **P**sychological disturbances, **P**ink urine, and **P**recipitated by drugs. * **Contraindicated Drugs:** Barbiturates, Sulfonamides, Carbamazepine, and Alcohol (all induce CYP450). * **Safe Drugs:** Gabapentin, Aspirin, and Morphine are generally considered safe in porphyria. * **Treatment of Acute Attack:** Intravenous **Hematin/Heme arginate** (provides negative feedback to inhibit ALAS1) and high-dose **Glucose** (suppresses ALAS1 transcription).
Explanation: **Explanation:** The synthesis of hemoglobin primarily involves the production of **Heme** and **Globin** chains. The correct answer is **Glycine** because it is a fundamental precursor in the Heme biosynthetic pathway. **1. Why Glycine is Correct:** The first and rate-limiting step of heme synthesis occurs in the mitochondria, where the enzyme **ALA Synthase** catalyzes the condensation of **Succinyl-CoA** (from the TCA cycle) and the amino acid **Glycine** to form $\delta$-aminolevulinic acid (ALA). This reaction requires Pyridoxal Phosphate (Vitamin B6) as a cofactor. Since heme is the prosthetic group of hemoglobin that binds oxygen, Glycine is indispensable for its formation. **2. Analysis of Incorrect Options:** * **Alanine (A):** While a common glucogenic amino acid, it does not participate in the specific biosynthetic pathway of the porphyrin ring. * **Arginine (C):** Arginine is vital for the Urea cycle and Nitric Oxide synthesis but is not a precursor for heme. * **Histidine (D):** Although Histidine plays a crucial role in the *structure* of hemoglobin (the "Proximal" and "Distal" histidines that anchor the heme iron), it is not a raw material required for the *synthesis* of the heme molecule itself. **Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** ALA Synthase (inhibited by Heme/Hematin). * **Cofactor:** Vitamin B6 deficiency can lead to **Sideroblastic Anemia** because ALA synthase cannot function without PLP. * **Lead Poisoning:** Lead inhibits **ALA Dehydratase** and **Ferrochelatase**, leading to increased ALA levels and stippled RBCs. * **Key Precursors:** Remember the mnemonic: **"Grapes and Soda"** (Glycine + Succinyl-CoA) for Heme synthesis.
Explanation: **Explanation:** In isolated heme (outside the globin protein), carbon monoxide (CO) binds to the ferrous iron ($Fe^{2+}$) 25,000 times more strongly than oxygen does. This is because CO prefers a **linear, vertical orientation** relative to the heme plane. However, in the hemoglobin molecule, this affinity is significantly reduced to about 200–250 times. **Why Histidine E7 is correct:** The **Distal Histidine (His E7)** is positioned on the side of the heme where gas binding occurs. It creates **steric hindrance** (spatial crowding) that forces CO to bind at an angle (bent geometry) rather than its preferred linear orientation. Conversely, oxygen naturally binds in a bent fashion, which is stabilized by a hydrogen bond from His E7. By weakening CO binding and strengthening $O_2$ binding, His E7 prevents endogenous CO (produced during heme catabolism) from displacing oxygen. **Analysis of Incorrect Options:** * **Histidine F8 (Proximal Histidine):** This residue is located on the opposite side of the heme. It coordinates directly with the iron atom, anchoring the heme to the globin chain. It does not interfere with the geometry of gas binding. * **Glycine B6 & Threonine C4:** These are structural residues within the alpha-helices of the globin chain. While they contribute to the overall fold of the protein, they do not interact directly with the heme iron or influence ligand affinity. **High-Yield Clinical Pearls for NEET-PG:** * **CO Poisoning:** CO binds to hemoglobin with 200x higher affinity than $O_2$, forming **Carboxyhemoglobin**. This causes a **left shift** in the oxygen dissociation curve, hindering $O_2$ release to tissues. * **Treatment:** 100% $O_2$ or Hyperbaric $O_2$ to competitively displace CO. * **Endogenous CO:** Small amounts of CO are produced naturally in the body by the enzyme **Heme Oxygenase** during the degradation of heme to biliverdin.
Explanation: **Explanation:** **Hb Barts** is a pathological hemoglobin tetramer composed of four gamma chains (**$\gamma_4$**). It occurs in **Alpha-thalassemia major** (Hydrops Fetalis), where all four $\alpha$-globin genes are deleted ($--/--$). **1. Why Option C is Correct:** The primary physiological defect of Hb Barts is its **extremely high oxygen affinity**. On the oxygen-dissociation curve, it is shifted significantly to the left. While Hb Barts can bind oxygen in the lungs/placenta with ease, its P50 is so low (approx. 12-15 mmHg compared to 27 mmHg for HbA) that it **fails to release oxygen** to the fetal tissues. This results in severe tissue hypoxia, high-output cardiac failure, and massive edema (hydrops), leading to intrauterine death. **2. Why Other Options are Incorrect:** * **Option A:** Hb Barts *can* bind oxygen; in fact, it binds it too tightly. * **Option B:** Excess $\alpha$-chains are seen in $\beta$-thalassemia, not $\alpha$-thalassemia. In $\alpha$-thalassemia major, there is a total absence of $\alpha$-chains, leading to an excess of $\gamma$-chains (forming Hb Barts) or $\beta$-chains (forming HbH). * **Option D:** While microcytosis is present, the lethality is due to hypoxia-induced heart failure, not mechanical trapping in the placenta. **Clinical Pearls for NEET-PG:** * **HbH Disease:** Deletion of 3 $\alpha$-genes ($--/-\alpha$); characterized by $\beta_4$ tetramers. * **Heinz Bodies:** Formed by precipitated HbH; visualized with **Supravital stains** (e.g., Brilliant Cresyl Blue) as "golf ball" inclusions. * **Electrophoresis:** Hb Barts is fast-moving (anodal) on alkaline electrophoresis. * **Management:** Intrauterine blood transfusions can sometimes salvage these pregnancies.
Explanation: ### Explanation **1. Why Heme Oxygenase is Correct:** The degradation of heme occurs primarily in the reticuloendothelial system (spleen and liver). **Heme oxygenase** is the rate-limiting enzyme in this pathway. It acts on the heme molecule, requiring NADPH and O₂, to cleave the alpha-methene bridge of the porphyrin ring. This reaction results in the formation of **biliverdin**, carbon monoxide (CO), and free ferrous iron (Fe²⁺). Biliverdin is subsequently reduced to **bilirubin** by the enzyme *biliverdin reductase*. Therefore, heme oxygenase is the initial and essential enzyme in the conversion process from heme toward bilirubin. **2. Why the Other Options are Incorrect:** * **Heme reductase:** This is not a recognized enzyme in the heme degradation pathway. The reduction step in this pathway is performed by *biliverdin reductase* (converting biliverdin to bilirubin), not a "heme" reductase. * **Heme isomerase:** Isomerases catalyze structural rearrangements. Heme degradation involves oxidative cleavage and reduction, not simple isomerization. * **Heme hydrolase:** Degradation of the porphyrin ring is an oxidative process, not a hydrolytic one (which would involve the addition of water). **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Carbon Monoxide (CO):** Heme oxygenase is the only endogenous source of CO in the human body. * **Inducibility:** Heme oxygenase-1 (HO-1) is an inducible isoform that increases in response to oxidative stress, while HO-2 is constitutive. * **Color Changes in Bruises:** The transition of a bruise from purple (heme) to green (biliverdin) to yellow (bilirubin) reflects the sequential action of these enzymes. * **Iron Recycling:** The iron released by heme oxygenase is sequestered by ferritin or transported by transferrin to be reused in erythropoiesis.
Explanation: **Explanation:** **1. Why Hepcidin is the Correct Answer:** Hepcidin is a peptide hormone synthesized by the liver and is the **master regulator** of systemic iron homeostasis. It controls the release of iron from stores (macrophages and hepatocytes) and its absorption from the diet (enterocytes) by binding to **Ferroportin**, the only known cellular iron exporter. * **Mechanism:** When hepcidin levels are high, it binds to ferroportin, causing its internalization and degradation. This "locks" iron inside the cells, preventing its release into the plasma. Conversely, low hepcidin levels allow ferroportin to remain active, facilitating iron release. **2. Why Other Options are Incorrect:** * **Transferrin:** This is the primary **transport protein** for iron in the blood. It delivers iron to tissues via transferrin receptors but does not regulate the release of iron from stores. * **Ferritin:** This is the primary **intracellular storage form** of iron. While serum ferritin levels reflect total body iron stores, ferritin itself is a storage shell, not a regulatory hormone. * **Hepoxin:** This is a metabolite of arachidonic acid (specifically Hepoxilin) involved in inflammation and insulin secretion; it has no role in iron metabolism. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Anemia of Chronic Disease (ACD):** Inflammatory cytokines (especially **IL-6**) increase hepcidin production. This leads to iron sequestration in macrophages, causing low serum iron despite adequate stores. * **Hereditary Hemochromatosis:** Often caused by a deficiency in hepcidin or its signaling pathway, leading to uncontrolled iron absorption and systemic overload. * **Stimuli for Hepcidin:** It is **increased** by iron overload and inflammation, and **decreased** by hypoxia and increased erythropoietic demand.
Explanation: **Explanation:** The correct answer is **Transferrin**. Iron metabolism is a high-yield topic for NEET-PG, focusing on the specific proteins involved in storage, transport, and regulation. **1. Why Transferrin is correct:** Iron absorbed from the diet (as $Fe^{2+}$) is oxidized to the ferric state ($Fe^{3+}$) by ferroxidase (ceruloplasmin) before entering the plasma. Once in the blood, it binds to **Transferrin**, a glycoprotein synthesized in the liver. Transferrin acts as the primary vehicle to transport iron through the circulation to the bone marrow (for erythropoiesis) and other tissues. Each transferrin molecule can bind two atoms of ferric iron. **2. Why the other options are incorrect:** * **Ferritin:** This is the primary **intracellular storage** form of iron. It is found mainly in the liver, spleen, and bone marrow. Serum ferritin levels are the most sensitive lab indicator for iron deficiency anemia. * **Haemosiderin:** This is an insoluble, partially degraded form of ferritin used for **long-term iron storage**. It is typically seen in states of iron overload (hemosiderosis). * **Myoglobin:** This is an iron-containing protein found in **muscle tissue** that stores oxygen locally; it does not function as a systemic iron transporter. **Clinical Pearls for NEET-PG:** * **Hepcidin:** The "Master Regulator" of iron. It inhibits iron absorption by degrading **Ferroportin** (the gatekeeper protein that releases iron from enterocytes/macrophages). * **TIBC (Total Iron Binding Capacity):** This is an indirect measure of transferrin levels. In Iron Deficiency Anemia (IDA), TIBC increases while Ferritin decreases. * **Atransferrinemia:** A rare genetic deficiency of transferrin leading to microcytic anemia and iron overload in tissues.
Explanation: **Explanation:** The correct answer is **Hemopexin**. **1. Why Hemopexin is correct:** Hemopexin is a plasma glycoprotein (β-globulin) synthesized by the liver. Its primary physiological role is to bind **free heme** with high affinity. When intravascular hemolysis occurs, hemoglobin is released; if this exceeds the binding capacity of haptoglobin, hemoglobin dissociates into globin and heme. The free heme is toxic as it promotes oxidative stress. Hemopexin binds to this free heme and transports it to the liver, where the complex is internalized via the CD91 receptor. This prevents heme-mediated oxidative damage and conserves iron. **2. Why other options are incorrect:** * **Ceruloplasmin (A):** This is the major copper-carrying protein in the blood. It also functions as a **ferroxidase**, converting Fe²⁺ (ferrous) to Fe³⁺ (ferric) so iron can bind to transferrin. It does not bind heme. * **Haptoglobin (B):** This protein binds to **free hemoglobin dimers** (not free heme). The haptoglobin-hemoglobin complex is too large to be filtered by the kidney, preventing hemoglobinuria and iron loss. * **Hemosiderin (D):** This is an insoluble **iron-storage complex** found within cells (macrophages), typically seen in states of iron overload. It is not a plasma transport protein. **Clinical Pearls for NEET-PG:** * **Haptoglobin levels** decrease in intravascular hemolysis because the complex is rapidly cleared by the reticuloendothelial system. * **Hemopexin levels** also drop in severe hemolysis once haptoglobin is saturated. * **Transferrin** transports free iron (Fe³⁺), while **Ferritin** is the primary intracellular storage form of iron.
Explanation: **Explanation:** The characteristic brown color of feces is primarily due to **Stercobilin**, a tetrapyrrolic pigment derived from the catabolism of heme. **Mechanism:** 1. **Heme Breakdown:** Senescent red blood cells are broken down in the Reticuloendothelial system (Spleen), converting Heme to Biliverdin and then to Unconjugated Bilirubin. 2. **Conjugation:** In the liver, bilirubin is conjugated with glucuronic acid and excreted into the bile. 3. **Intestinal Transformation:** In the distal ileum and colon, bacterial enzymes deconjugate bilirubin and reduce it into colorless **Urobilinogen**. 4. **Oxidation:** Most urobilinogen is oxidized by intestinal bacteria into **Stercobilin**, which is excreted in the stool, providing its brown pigment. **Analysis of Incorrect Options:** * **A. Biliverdin:** A green pigment produced during the first step of heme degradation. It is responsible for the greenish color seen in bruises or the bile of some animals, but not the brown color of stool. * **B. Urobilinogen:** This is a colorless precursor. While some is reabsorbed (enterohepatic circulation) and excreted in urine as yellow **Urobilin**, it does not provide the brown color itself until oxidized to stercobilin. * **C. Heme:** The iron-protoporphyrin complex in hemoglobin. Free heme is toxic and does not reach the stool under physiological conditions; if present (e.g., upper GI bleed), it typically turns stool black (melena). **Clinical Pearls for NEET-PG:** * **Clay-colored stools:** Occur in **Obstructive Jaundice** because bile cannot reach the intestine, leading to a deficiency of stercobilin. * **Urobilinogen in Urine:** Increased in hemolytic jaundice; absent in complete obstructive jaundice. * **Rate-limiting step of bilirubin metabolism:** The secretion of conjugated bilirubin into the bile canaliculi (defective in Dubin-Johnson syndrome).
Hemoglobin Structure and Function
Practice Questions
Oxygen Transport and Oxygen-Hemoglobin Dissociation Curve
Practice Questions
Hemoglobin Variants and Hemoglobinopathies
Practice Questions
Thalassemias
Practice Questions
Methemoglobin and Abnormal Hemoglobins
Practice Questions
Hemoglobin Synthesis
Practice Questions
Heme Synthesis and Porphyrias
Practice Questions
Iron Absorption and Transport
Practice Questions
Iron Storage and Recycling
Practice Questions
Disorders of Iron Metabolism
Practice Questions
Anemia: Biochemical Aspects
Practice Questions
Biochemistry of Hemostasis
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free